Form D · Biotechnology
Forte Biosciences, Inc.
Torrance, CA · CIK 0001761323
Offering snapshot reported Jun 15, 2020 · SEC filing
- Reported sold
- $19.4M Offering amount: $20M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 15, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 15, 2020 | Initial | $19,435,002 | No comparison | 19 | SEC filing |
| Dec 11, 2018 | Initial | $5,756,621 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-369003
Source: Form D, filed Jun 15, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lawrence Eichenfield | Director |
| Tuan Huynh | Director |
| Antony Riley | Executive |
| Paul Wagner | Director, Executive |
| Paul A. Wagner, Ph.D. | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1124 W. Carson Street Mrl Building 3 320
Torrance, CA, 90502
Torrance, CA, 90502